| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Shandong Weigao Orthopaedic Device Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥26.49 |
| 52 Week High | CN¥49.32 |
| 52 Week Low | CN¥22.50 |
| Beta | 0.40 |
| 1 Month Change | 15.68% |
| 3 Month Change | -14.58% |
| 1 Year Change | -44.81% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -56.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688161 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 2.4% | -1.1% | 1.1% |
| 1Y | -44.8% | -13.2% | -10.2% |
Return vs Industry: 688161 underperformed the CN Medical Equipment industry which returned -13.2% over the past year.
Return vs Market: 688161 underperformed the CN Market which returned -10.2% over the past year.
Price Volatility
| 688161 volatility | |
|---|---|
| 688161 Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in CN Market | 10.7% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 688161's share price has been volatile over the past 3 months.
Volatility Over Time: 688161's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 2,210 | n/a | www.weigaoholding.com/group_list/61.html |
Shandong Weigao Orthopedic Device Co., Ltd. operates as a medical device and pharmaceutical company. It offers spine, trauma, joints, sports medicine, and bone repair materials, as well as offers orthopedic surgical instruments.
Shandong Weigao Orthopaedic Device Co., Ltd Fundamentals Summary
| 688161 fundamental statistics | |
|---|---|
| Market cap | CN¥10.55b |
| Earnings (TTM) | CN¥53.08m |
| Revenue (TTM) | CN¥1.24b |
189.6x
P/E Ratio8.1x
P/S RatioIs 688161 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688161 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.24b |
| Cost of Revenue | CN¥499.90m |
| Gross Profit | CN¥741.78m |
| Other Expenses | CN¥688.70m |
| Earnings | CN¥53.08m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 59.74% |
| Net Profit Margin | 4.28% |
| Debt/Equity Ratio | 0% |
How did 688161 perform over the long term?
See historical performance and comparison